본문 바로가기
KERD
논문KCI 등재

Recent Chemotherapy Reduces the Maximum-Standardized Uptake Value of 18F-Fluoro-Deoxyglucose Positron Emission Tomography in Colorectal Cancer

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Background/Aims: The aim of this study was to evaluatethe influence of recent chemotherapy on the patterns of themaximum-standardized uptake value (M-SUV) and sensitivityof 18F-fluoro-deoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) in colorectal cancer. Methods: We retrospectively analyzed the FDG-PET/CT of509 patients who underwent surgery for colorectal cancer. Subgroup analysis was performed according to chemotherapystatus; 401 patients were not treated with chemotherapyand 108 patients were treated with chemotherapywithin 6 months prior to surgery. Pathologic analysis of thesurgical specimen was used as the gold standard. Results:The M-SUV was significantly lower in patients treated withchemotherapy than in those not treated with chemotherapyin pathologically confirmed same stages of disease. Thedifference in the sensitivity of the M-SUV according to chemotherapystatus was greatest using a cutoff M-SUV valueof 6.4 (p<0.001). The longest diameter of the primary tumorwas the most important factor that correlated with M-SUV ofthe primary tumor irrespective of the chemotherapy effect(p<0.001). The M-SUV of the primary tumor was not an independentpredictor of lymph node metastasis in colorectalcancer. Conclusions: The results indicate that the M-SUV ofFDG-PET/CT should be interpreted in the context of concurrentchemotherapy.

Abstract

Background/Aims: The aim of this study was to evaluatethe influence of recent chemotherapy on the patterns of themaximum-standardized uptake value (M-SUV) and sensitivityof 18F-fluoro-deoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) in colorectal cancer. Methods: We retrospectively analyzed the FDG-PET/CT of509 patients who underwent surgery for colorectal cancer. Subgroup analysis was performed according to chemotherapystatus; 401 patients were not treated with chemotherapyand 108 patients were treated with chemotherapywithin 6 months prior to surgery. Pathologic analysis of thesurgical specimen was used as the gold standard. Results:The M-SUV was significantly lower in patients treated withchemotherapy than in those not treated with chemotherapyin pathologically confirmed same stages of disease. Thedifference in the sensitivity of the M-SUV according to chemotherapystatus was greatest using a cutoff M-SUV valueof 6.4 (p<0.001). The longest diameter of the primary tumorwas the most important factor that correlated with M-SUV ofthe primary tumor irrespective of the chemotherapy effect(p<0.001). The M-SUV of the primary tumor was not an independentpredictor of lymph node metastasis in colorectalcancer. Conclusions: The results indicate that the M-SUV ofFDG-PET/CT should be interpreted in the context of concurrentchemotherapy.

참고문헌 (29)

  1. American Cancer Society, "Cancer facts & figures 2011" (2011), American Cancer Society
  2. Weber WA, "Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging", J Clin Oncol, 19, pp.3058~3065 (2001)
  3. Brun E, "FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma", Head Neck, 24, pp.127~135 (2002)
  4. Mac Manus MP, "Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer", J Clin Oncol, 21, pp.1285~1292 (2003)
  5. Martoni AA, "Early (18)F-2-fluoro-2-deoxy-d-glucose positron emission tomography may identify a subset of patients with estrogen receptor-positive breast cancer who will not respond optimally to preoperative chemotherapy", Cancer, 116, pp.805~813 (2010)
  6. Amthauer H, "Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology", Eur J Nucl Med Mol Imaging, 31, pp.811~819 (2004)
  7. Calvo FA, "18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation", Int J Radiat Oncol Biol Phys, 58, pp.528~535 (2004)
  8. Denecke T, "Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?", Eur Radiol, 15, pp.1658~1666 (2005)
  9. Guillem JG, "Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer", J Am Coll Surg, 199, pp.1~7 (2004)
  10. Oku S, "FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer", Ann Nucl Med, 16, pp.409~416 (2002)
  11. de Geus-Oei LF, "Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer", Ann Oncol, 19, pp.348~352 (2008)
  12. Rosen D, "Correlation of tissue biopsy and fine needle aspiration cytology with positron emission tomography results", Patholog Res Int, 2011, pp.323051~ (2011)
  13. Lee JE, "Prognostic value of 18-fluorodeox yglucose positron emission tomography-computed tomography in resectable colorectal cancer", World J Gastroenterol, 18, pp.5072~5077 (2012)
  14. Luboldt W, "Detection of relevant colonic neoplasms with PET", CT: promising accuracy with minimal CT dose and a standardised PET cut-off, 2010, pp.20, 2274~2285
  15. Martoni AA, "Prospective study on the FDG-PET", CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer, 2011, pp.22, 650~656
  16. Glazer ES, "Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases", Arch Surg, 145, pp.340~345 (2010)
  17. Uchiyama S, "Role of the standardized uptake value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in detecting the primary tumor and lymph node metastasis in colorectal cancers", Surg Today, 42, pp.956~961 (2012)
  18. Japanese Society for Cancer of the Colon and Rectum, "Japanese classification of colorectal carcinoma" (1997), Kanehara Co
  19. Higashi T, "FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors", J Nucl Med, 39, pp.1727~1735 (1998)
  20. Aloj L, "Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture", Cancer Res, 59, pp.4709~4714 (1999)
  21. Rabkin Z, "Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET", CT studies in patients evaluated for infection or inflammation and cancer? A comparative analysis, 2010, pp.51, 1015~1020
  22. Sugawara Y, "Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling", Radiology, 211, pp.249~256 (1999)
  23. Goldberg N, "Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging: a prospective clinical study", Radiat Oncol, 7, pp.124~ (2012)
  24. Hong R, "18F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma", World J Gastroenterol, 18, pp.168~174 (2012)
  25. O’Connell JB, "Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging", J Natl Cancer Inst, 96, pp.1420~1425 (2004)
  26. Kudo SE, "Flat and depressed types of early colorectal cancers: from East to West", Gastrointest Endosc Clin N Am, 18, pp.581~593 (2008)
  27. Lee SY, "Microsatellite alterations at selected tetranucleotide repeats are associated with morphologies of colorectal neoplasias", Gastroenterology, 139, pp.1519~1525 (2010)
  28. Oh HH, "The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer", J Surg Oncol, 104, pp.530~533 (2011)
  29. Mochiki E, "Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer", World J Surg, 28, pp.247~253 (2004)

관련 논문AI추천

Relationship between Preoperative 18F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Status in Primary Colorectal Cancer권미정, 김민정, 이봉화, 최윤정, 황희성연세대학교의과대학 · Yonsei Medical Journal2016 · 제57권 제1호The Role of 18^F-FDG PET/CT in the Evaluation of Gastric Cancer Recurrence after Curative Gastrectomy강민경, 고광현, 권창일, 박필원, 안대호, 임규성, 전태주, 홍성표, 황성규, Ji Eun Lee연세대학교의과대학 · Yonsei Medical Journal2011 · 제52권 제1호The Clinical Meaning of Benign Colon Uptake in 18F-FDG PET: Comparison with Colonoscopic Findings김범산, 김성은, 김태헌, 문일환, 심기남, 정성애, 정혜경, 태정현, Hye-In Kim, Ju Young Choi, Kwon Yoo, Min Jin Lee, Sun Hee Roh대한소화기내시경학회 · Clinical Endoscopy2012 · 제45권 제2호Prognostic Value of 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Resectable Pancreatic Cancer강창무, 김주항, 송시영, 윤미진, 이우정, 이재훈, 이종두, 조응혁, 최혜진연세대학교의과대학 · Yonsei Medical Journal2013 · 제54권 제6호Clinical Value of Whole Body F-18 FDG PET in The Management of Recurrent Colorectal Malignancy강건욱, 강성범, 박규주, 박재갑, 양한광, 이동수, 임석병, 정준기, 허승철, Hyo Seong Choi, Jae-Min Jeong, Kyung-Hoon Hwang, Myung Chul Lee, Seung-Yong Jeong, Young Jin Park대한암학회 · Cancer Research and Treatment2003 · 제35권 제4호Response Evaluation after Neoadjuvant Chemoradiation by Positron Emission Tomography-Computed Tomography for Esophageal Squamous Cell Carcinoma김관민, 김도훈, 문승환, 박준석, 심영목, 안용찬, 이지연, 최준영대한암학회 · Cancer Research and Treatment2013 · 제45권 제1호

이 간행물의 다른 논문 (15건)